跳至主要内容
临床试验/CTRI/2023/11/060279
CTRI/2023/11/060279招募中Unknown

An observational study of the Efficacy and Safety between Intralesional Triamcinolone Acetonide(4mg/ml) And Modified Kligmans Formula in Treatment of Melasma - Nil

Aishwarya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically diagnosed and consenting patients with melasma

排除标准

  • 1. Pregnant and lactating mothers
  • 2. Patients with other facial hyperpigmented dermatoses, telangiectasia or Autoimmune disorder
  • 3. Non consenting patients
  • 4. Patients with unrealistic expectations
  • 5. Patients who are already on treatment will be included after a wash out period of 1 month

研究者

发起方
Aishwarya

相似试验